mHealth Intervention in Increasing HPV Vaccinations in College Students

Not Applicable

Completed

• Conditions: Healthy Subject
• Interventions: Other: Media Intervention; Other: Informational Intervention; Other: Survey Administration

• Registration Number: NCT02960100
• Lead Sponsor: Ohio State University Comprehensive Cancer Center

Brief Summary

This randomized pilot trial studies how well a mobile health (mHealth) intervention works in increasing human papillomavirus (HPV) vaccination among college students at the Ohio State University. mHealth educational intervention may communicate information about HPV vaccination and increase HPV vaccine uptake in college students.

Detailed Description

PRIMARY OBJECTIVES:

I. Pilot test an mHealth HPV vaccine intervention for college students to establish feasibility and acceptability.

II. Obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group.

SECONDARY OBJECTIVES:

I. Examine whether the mHealth HPV vaccine intervention affects secondary outcomes compared to the control group.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message.

ARM II: Participants receive standard information about HPV and then HPV vaccine information statement (VIS) via the mobile-friendly website.

After completion of study, participants are followed up at 3 and 7 months.

Study Timeline

• Study Start: 2016-10-18
• Study First Submitted: 2016-11-07
• Study First Submitted QC: 2016-11-07
• Study First Posted: 2016-11-09
• Primary Completion: 2017-08-31
• Study Completion: 2017-08-31
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-19
• Last Update Posted: 2018-02-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 101

Inclusion Criteria

• Currently enrolled as a first year Ohio State University (OSU) student on the Columbus campus
• Being able to read English
• Not having received any doses of the HPV vaccine

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Arm I (mHealth HPV vaccine intervention)	Survey Administration	Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message.
Arm I (mHealth HPV vaccine intervention)	Media Intervention	Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message.
Arm II (standard HPV information and HPV VIS)	Informational Intervention	Participants receive standard information with the HPV Vaccine Information Statement via the mobile-friendly website.
Arm II (standard HPV information and HPV VIS)	Survey Administration	Participants receive standard information with the HPV Vaccine Information Statement via the mobile-friendly website.

Primary Outcome Measures

Name	Time	Method
Receipt of the first dose of HPV vaccine in intervention and control group	Up to 7 months	Will obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group.
Participant satisfaction scores	Up to 7 months	Acceptability and feasibility will be established by examining participant satisfaction with study materials.

Trial Locations

Locations (1)

Ohio State University Comprehensive Cancer Center; 🇺🇸 Columbus, Ohio, United States